Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

Improving emergency evaluation and transfer protocols for stroke patients

Official title: Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Run by University of Chicago · NCT06094478 · Data updated 2026-11-12

This study is testing a new way to speed up the transfer of stroke patients to specialized hospitals to see if it helps them get better faster.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment900 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations8 sites (New Haven, Connecticut and 7 other locations)
StatusRecruiting
StartedOctober 17, 2024
Main results expectedJanuary 31, 2028
Study endsJuly 31, 2028
Registry record updatedMay 20, 2026
Trial IDNCT06094478 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have been diagnosed with acute ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage.

Probably not a fit

Patients who are under 18 years old, diagnosed with transient ischemic attack, or those receiving comfort care measures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the evaluation and transfer process for stroke patients who require advanced care at comprehensive stroke centers. By implementing a novel, evidence-based protocol called HI-SPEED across eight diverse stroke systems in the US, the study seeks to reduce the time it takes for patients to be transferred from non-comprehensive hospitals to those that can provide specialized treatment. The effectiveness of this intervention will be evaluated based on median transfer times and patient disability outcomes, while also assessing the quality of implementation. The study leverages interdisciplinary expertise in stroke care and aims to establish a model for widespread dissemination of improved protocols.

Why it matters

Potential benefit: If successful, this study could significantly reduce transfer times for stroke patients, leading to better treatment outcomes and reduced disability.

How similar studies have gone: Previous studies have shown success in implementing similar protocols to reduce transfer times and improve outcomes for stroke patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>=18 years
* Final diagnosis: AIS, ICH, or SAH

Exclusion Criteria:

* Final diagnosis: TIA or stroke NOS
* Age \<18 years
* Comfort care measures on day 0 or 1
* Left hospital against medical advice
* Enrolled in clinical trial related to stroke that is competing with this study

Where it's running

  • Yale New Haven Hospital
    New Haven, Connecticut, United States
    Recruiting
  • Jackson Memorial Hospital
    Miami, Florida, United States
    Recruiting
  • Emory University Hospital
    Atlanta, Georgia, United States
    Recruiting
  • UChicago Medicine Ingalls Memorial Hospital
    Chicago, Illinois, United States
    Recruiting
  • University of Michigan Hospital
    Ann Arbor, Michigan, United States
    Recruiting
  • New York Presbyterian - Weill Cornell Hospital
    New York, New York, United States
    Recruiting
Show 2 more locations
  • University of Cincinnati Medical Center
    Cincinnati, Ohio, United States
    Recruiting
  • University of Utah Health
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Effectiveness of a new neurorehabilitation technology for stroke recovery

    This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.

    Recruiting Neurotechnika · Samara, Samara Oblast · NCT06753006

  • Using AI to speed up transfers for stroke patients needing thrombectomy

    This study tests if using an AI tool can help speed up the transfer of stroke patients to hospitals that can provide a special treatment called thrombectomy.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Granollers, Barcelona and 1 other locations · NCT06741332

  • Music therapy after stroke

    This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.

    Recruiting Universidad de Granada · Granada, Granada · NCT07899034

  • Endovascular therapy plus standard care vs standard care alone for distal and medium vessel strokes

    In people with acute ischemic stroke due to distal or medium vessel blockages, this study tests whether adding endovascular treatment to the usual medical care helps improve outcomes compared with medical care alone.

    Recruiting Hospital Universitari Vall d'Hebron Research Institute · Barcelona, Barcelona · NCT07843797

  • Inter-Limb Transfer after Acute Stroke

    This study tests whether practicing motor skills with the affected arm helps improve movement in the other arm after an acute stroke.

    Recruiting at 2 sites University Hospital of Mont-Godinne · Yvoir, Namur and 1 other locations · NCT07822633

  • AI-powered decision support to boost thrombolysis for ischemic stroke

    This trial tests whether an AI-assisted decision tool helps doctors give intravenous thrombolysis to eligible ischemic stroke patients within 24 hours at a primary hospital in China, compared with standard care.

    Recruiting Capital Medical University · Changsha, Hunan · NCT07785492

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.